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Abstract
Purpose This study investigated whether there is a cor-
relation between levels of 25OH-D in the follicular fluid
and the serum of infertile women and the results of IVF and
rates of pregnancy. The association between the levels of
25OH-D in the follicular fluid and the vitamin D repletion
status was also assessed.
Methods Two hundred and twenty-one infertile women
participated in an IVF cycle from 2010 to 2011 in a pro-
spective observational study. Serum and follicular fluid
were collected for vitamin D analysis. Deficient, insuffi-
cient, and sufficient levels of vitamin D were defined as 10,
10–29, and 30–100 ng/ml, respectively. IVF cycle param-
eters and clinical pregnancy rates were also compared with
the vitamin D level.
Results The levels of vitamin D deficiency, insufficiency,
and sufficiency were 22.6, 70.1, and 7.2 %, respectively.
The fertilization rates associated with these three levels of
vitamin D were 43.17, 53.37, and 58.77 %, respectively,
(P = 0.054), and the implantation rates were 17.33, 15.26,
and 18.75 %, respectively, (P = 0.579). No significant
correlation was seen between the pregnancy rate and the
serum vitamin D level (P = 0.094) or the follicular
vitamin D level (P = 0.170). The serum and follicular fluid
vitamin D levels showed a significant correlation
(P = 0.000).
Conclusion Although vitamin D is an important hormone
in the human body, no correlation was found between the
serum and follicular vitamin D level and the pregnancy rate
in the IVF cycle.
Keywords Vitamin D  IVF  Follicular fluid 
Pregnancy rate  250H-D
Introduction
Vitamin D plays important clinical roles in the human body
thanks to its interrelationship with bone metabolism and
calcium homeostasis [1]. Many cells in the human body
contain vitamin D receptors. Given the interrelationship
between bone metabolism and calcium homeostasis, any
deficiency in vitamin D may result in several health risks.
Many studies have addressed the association between
vitamin D deficiency and an increased risk of cancer,
autoimmune diseases, diabetes, rheumatoid arthritis, mul-
tiple sclerosis, and cardiac diseases [2].
Pregnant women with vitamin D deficiency show
increased risks of pregnancy complications, such as pre-
eclampsia [3] and bacterial vaginosis [4]. Vitamin D sup-
plementation has been found to cause a 50 % decrease in
premature labor pains, a 25 % reduction in bacterial vag-
inosis, and a 30 % decline in diabetes, hypertension, and
preeclampsia [5].
Heaney et al. [6] described the functions of vitamin D in
a wide range of physiological processes. They found that it
has a critical role in the regulation of cellular growth and
metabolic modulations related to insulin. Vitamin D
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deficiency was also found to be associated with insulin
resistance via a mechanism involving stimulation of the
expression of insulin receptors. Research has also shown
that the regulation of intra- and extracellular calcium and
modulators have profound effects on the immune system
[7].
Vitamin D is associated with steroidogenesis of estradiol
and progesterone. Levels of the vitamin were reported to be
increased in endometriosis [8]. The relationship between
vitamin D and steroidogenesis was affected by calcium
homeostasis and the direct regulation of the expression of
the aromatase gene [9]. It was also reported that vitamin D
regulates HOXA10 in the stromal cells of the endometrium
and that this, is in turn, aids implantation and uterine
receptivity [1].
Seasonal changes in vitamin D levels are known to
influence endometrial and oocyte development [10].
Hypersensitivity to vitamin D can also occur. The most
common example is primary hyperparathyroidism [11].
Limited data suggest that excessive serum and follicular
vitamin D negatively affect IVF [12]. Further clarifica-
tion is needed on the relationship between vitamin D and
IVF outcomes. Previous studies assessed vitamin D in
IVF cycles using different protocols because different
drugs have dissimilar effects on follicular fluid sub-
stances [13]. This study aimed to demonstrate the role of
vitamin D in Iranian patients undergoing IVF with one
single protocol.
Materials and methods
In a prospective cohort study from September 2010 to
September 2011, 221 patients were selected, and they
provided informed consent to participate in the study. The
study was approved by the Ethics Committee of Yazd
Research and Clinical Center for Infertility of Shahid Sa-
doughi University of Medical Sciences. The inclusion
criteria were acceptance of the standard long protocol,
(Follicular stimulating hormone) FSH\10(IU/L), and aged
between 20 and 39 years. The exclusion criteria were liver,
kidney, or heart disease; a severe male factor; endometriosis;
Cushing’s syndrome; hyper- or hypothyroidism; hyperpro-
lactinemia; or a body mass index of more than 29 kg/m2 or
less than 18 kg/m2. The primary outcome was chemical
pregnancy, and the secondary outcome was the determina-
tion of follicular and serum vitamin D levels. All the patients
received the long protocol, starting with 0.5 mg/day of
Buserelin Acetate (Suprefact, Aventis Pharma Deutschland,
Germany) in the midluteal phase. After menstruation and the
completion of pituitary suppression (FSH B5 IU/ml,
(Luteinizing Hormone) LH B5 IU/ml, estradiol B50 pg/ml,
and progesterone B1 ng/ml), Suprefact was decreased to
0.25 mg/day and continued until the day of ovum pick-up.
Gonal-F (Gonal-F, Serono, Italy) was initiated from the
second day of menses according to the patient’s age and
antral follicular count. The dose of Gonal-F was adjusted by
sonography and estradiol. The sonography was conducted on
the seventh day and repeated as needed. When the follicular
size reached 18–20 mm, HCG (Pregnyl, Daropakhsh, Iran)
10,000 IU was administered. After 34–36 h, transvaginal
ultrasound-guided ovum pick-up was performed. On the day
of ovum pick-up, follicular fluid was collected from follicles
more than 14 mm. Serum samples were obtained to deter-
mine the level of vitamin D. The sera were separated by
centrifugation, and the samples were frozen at -20 C.
When all the samples had been collected, vitamin D was
assayed. The vitamin D was checked by enzyme immuno-
assay (25-hydroxy vitamin D EIA kit, IDS Ltd., Cat. Nos.:
AC-57F1 and AC-57F2, UK). Meanwhile, high-quality fresh
embryos (i.e., seven or more blastomeres on day three with
20 % fragmentation or less) were transferred on the third day
after intracytoplasmic sperm injection by Labotect catheter
(Labotect, Gotting, Germany). The luteal phase was sup-
ported by 400 mg of Cyclogest (Actavis, Barnstaple, and
UK) vaginally two times per day. The administration started
on the day after the oocyte was retrieved. The serum bhCG
was also checked 14 days after the embryo transfer. In case
of pregnancy, Cyclogest was continued until the tenth week
of gestation. Clinical pregnancy was confirmed by trans-
vaginal sonography with at least one gestational sac in the
uterine cavity. Serum vitamin D levels were defined as
deficient (\10 ng/ml), insufficient (10–29 ng/ml), or suffi-
cient (30–100 ng/ml). If the patients had any adverse reac-
tions‘ they were kept under close observation and
management at the study center.
The data were analyzed using the SPSS version 16
computer program. The continuous variables were deter-
mined as the mean ± standard deviation or median val-
ues.The normality of quantitative data was assessed by
histogram and the one sample Kolmogorov–Smirnov test.
As the continuous data had a non-parametric distribution,
the data of the two groups were compared using the Mann–
Whitney U test. A Chi-square was used to compare the
qualitative variables where variables had a normal distri-
bution; an independent sample t test was used to adjust the
age and FSH of the patients. The Mann–Whitney test was
used to adjust the duration of infertility, etiology, LH,
Thyroid stimulating hormone (TSH), Prolactin, and estra-
diol of the patients and to compare the numbers of their
oocytes and embryos and their endometrial thickness.
A Chi-square test was also carried out to compare the
numbers of follicles and embryo transfers and the doses of
gonadotropin administered to the patients. Spearman’s
correlation test was utilized to determine the relationship
between the serum and follicular fluid vitamin D.
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Moreover, a Kruskal–Wallis test was employed to mea-
sure the fertilization and implantation rates based on the
vitamin D level. P values \0.05 were considered signifi-
cant. The final study comprised 180 patients, with the
confidence interval set at 95 %, the power at 80 %,
the prevalence of vitamin D deficiency about 60 %, and the
error at 10 %.
Results
The subjects of this study were 221 women. The patients’
demographic characteristics are described in Tables 1 and
2. The vitamin D in the serum was at an insufficient level in
155 patients (75.1 %), at a deficient level in 50 patients
(22.6 %), and at a sufficient level in 16 patients (7.2 %)
(Fig. 1). Among all the patients, 74 (33.48 %) had a
positive clinical pregnancy. The pregnant group was
compared with the non-pregnant group in terms of the level
of vitamin D in the serum (Table 3). There was no sig-
nificant difference between the two groups (Pearson Chi-
square, P = 0.094). The level of vitamin D in the follicular
fluid of the pregnant group was 22.17 ± 17.21 ng/ml. It
was 26.14 ± 19.33 ng/ml in the non-pregnant group.
However, this difference was not significant (Mann–
Whitney test, P = 0.17) (Fig. 2). The correlation between
the vitamin D levels in the serum and in the follicular fluid
was calculated using Spearman’s test. A correlation of
r = 0.83 showed that the result was significant
(P = 0.001) (Fig. 3), with the follicular vitamin D directly
reflecting the stocks of the vitamin in the body. Good-
quality embryos in the deficient, insufficient, and sufficient
groups occurred at rates of 82.6, 90.2, and 86.7 %,
respectively. There was no significant difference between
the various levels of vitamin D (P = 0.372). The fertil-
ization rates in the deficient, insufficient, and sufficient
groups were 43.17, 53.37, and 58.77 %, respectively,
(Kruskal–Wallis H test, P = 0.054), and the implantation
rates were 17.33, 15.26, and 18.75 %, respectively. There
was no significant difference between the results (Kruskal–
Wallis H test, P = 0.579) (Table 4).
Discussion
The results demonstrated that there was no correlation
between the amount of vitamin D in serum and follicular
fluid and IVF outcomes, although Anifandis and Ozkan
[12, 14] reported a direct association between vitamin D
levels and IVF success. Rudick et al. [15] demonstrated
that deficiency in vitamin D resulted in lower pregnancy
rates for non-Asian patients but not for Asian patients.
They added that the lack of association between vitamin D
levels and IVF success in Asian patients was probably due
to the fact that they had lower IVF pregnancy rates. The
current study of Asian patients found the same results.
Rudick et al. [16] also suggested that vitamin D deficiency
was not associated with the number of follicles and oocytes
or with the morphology of the embryo. Another study
suggested that the effect of this deficiency on the preg-
nancy rate may be realized through the endometrium. In a
similar study, Aleyasin et al. [17] suggested that vitamin D
deficiency had no correlation with IVF outcomes. Estes
et al. [18] demonstrated that proteomic analysis of follic-
ular fluid had potential as a biomarker of good responders
versus poor responders in IVF. The current study found
that vitamin D in the follicular fluid was the same in the
pregnant and non-pregnant groups.
Table 1 Demographic
characteristic of patients and
IVF outcomes
P values \0.05 was significant
a Median, comparison was
performed by Student’s t test or
Mann–Whitney test as
appropriate
Pregnant group Non-pregnant group P value
N = 74 (33.48 %) N = 147 (66.51 %)
Mean ± SD
Age (years) 29.1 ± 4.67 29.51 ± 4.77 0.873
Duration of infertility (years) 6.53 ± 4.54 7.01 ± 4.53 0.306
FSH (IU/L) 6.07 ± 2.15 6.07 ± 1.86 0.998
LH (IU/L) 5.56 ± 4.07 5.31 ± 3.79 0.768
TSH (l/L) 2.26 ± 1.84 2.4 ± 1.32 0.847
Prolactin (ng/mL) 18.23 ± 10.26 17.19 ± 9.06 0.614
Estradiol on day of HCG (pg/ml) 1,000a 1,100a 0.449
Number of follicles (n) 11.71 ± 7.41 10.73 ± 5.78 0.321
Number of oocytes (n) 9.75 ± 7.4 8.39 ± 5.2 0.343
Total number of embryos (n) 4.73 ± 3.46 3.9 ± 3.04 0.041
Total number of embryo transfers (n) 2.3 ± 0.56 2.21 ± 0.75 0.389
Total dose of gonadotropin (IU) 2253.04 ± 745.8 2356.63 ± 722.4 0.326
Endometrial thickness (mm) 9.82 ± 1.59 9.49 ± 1.63 0.221
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Vitamin D has a variety of functions, including the
stimulation of ovarian steroidogenesis and the production
of Insulin-like growth factor-binding protein-1 (IGFBP-1)
in ovarian cells through vitamin D receptors. Insulin and
vitamin D stimulate estradiol, estrone, and progesterone
production. Vitamin D also improves the inhibitory effect
of insulin on IGFBP-1 production [19]. Therefore, if there
is an increase in the level of vitamin D and a decrease in
the level of glucose follicular fluid, it will have a negative
effect on the embryo score [12]. Vitamin D induces the
transcription of HOXA10 (an important gene for implan-
tation) through vitamin D receptors. Treatment with vita-
min D increases mRNA and protein expression of
HOXA10. Vitamin D also has a direct impact on the reg-
ulation of HOXA10, and this has implications for fertility
[20]. Ozkan et al. [14] referred to this effect in their
research study. They reported that normal vitamin D levels
in serum improve the IVF outcome. They further proposed
that excess vitamin concentrations play a decisive role in
endometrial receptivity because 25-OH vitamin D recep-
tors were identified in the endometrium [14]. Rudick et al.
[16] stated that vitamin D may have an effect on the








Male factor 36 (48.6 %) 81 (55.1 %)
Tubal factor 14 (18.9 %) 13 (8.8 %)
Endometriosis 3 (4.1 %) 8 (5.4 %)
Poly cystic ovarian
syndrome
11 (14.9 %) 21 (14.3 %) 0.748
Unexplained infertility 10 (13.5 %) 24 (16.3 %)
Total patients 74 (33.48 %) 147 (66.51 %)
Mann–Whitney test, P values \0.05 was significant
Fig. 1 Prevalence of vitamin D in the study group
Table 3 Comparison of vitamin D levels in both groups
Groups Vitamin D P value
\10 ng/ml 10–29 ng/ml 30–100 ng/ml
Pregnant 23 (31.1 %) 47 (63.5 %) 4 (5.4 %) 0.094
Non-pregnant 27 (18.4 %) 108 (73.5 %) 12 (8.2 %)
Correlation between vitamin D and pregnancy by Pearson Chi-square
P value \0.05 was significant
Fig. 2 Correlation of follicular vitamin D and pregnancy. Mann–
Witney test, P value = 0.17 was not significant
Fig. 3 Correlation of follicular and serum vitamin D. Spearman
correlation, r = 0.83; P value = 0.001
Table 4 Comparison of fertilization and implantation rate according
to vitamin D level









43.17 % 53.37 % 58.77 % 0.054
Implantation
rate
17.33 % 15.26 % 18.75 % 0.579
Kruskal–Wallis H Test, P value \0.05 not significant
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endometrium in donor-recipient patients. However, this
idea seems to be in contrast with the finding of decreased
expression of the vitamin D binding protein in the follicular
fluid of an IVF success group reported by Estes et al. [17].
Vitamin D has also been reported to be related to obesity
and to endocrine and metabolic factors in polycystic
ovarian syndrome [1, 21, 22]. Vitamin D supplementation
was shown to improve menstrual cycle disturbances and
metabolic disturbances [23, 24]. Anifandis et al. [12] sug-
gested that increased follicular fluid vitamin D concentra-
tions ([30 ng/ml) can affect the action of insulin, resulting
in the modulation of follicular fluid glucose metabolism.
High serum levels of vitamin D may increase the con-
sumption of insulin. This condition appears to be undesir-
able because it has a direct negative impact on oocyte
maturation, the growth of granulosa and cumulus cells, and
the embryo quality and consequently on the IVF outcome.
Therefore, high and low levels of vitamin D have an
adverse effect on the IVF cycle. It is noteworthy that due to
time limitations, the number of patients who participated in
this study was limited.
Conclusion
The prevalence of vitamin D insufficiency was very high
among the patients who participated in this study. How-
ever, no significant correlation was found between preg-
nancy outcomes and vitamin D levels. These findings may
be related to the sample size. However, in the group who
had a sufficient level of vitamin D, there was a trend
toward increased implantation and fertilization. All
patients are advised to take vitamin D supplements due to
benefits such as bone health, pregnancy health, and
decreasing chronic diseases. There is scope for more
research projects about vitamin D. Future research could
include case-control studies of patients with vitamin D
supplementation undergoing IVF treatment.
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